Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics Life Science Investing
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer Life Science Investing
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director Life Science Investing
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® for Familial Chylomicronemia Syndrome in China Life Science Investing
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
